₹2,961.90
+51.25 (+1.76%)
As of 21 Sept 2026, Gland Pharma Ltd share price is ₹2,961.90. The stock opened at ₹2,961.90 and had closed at ₹2,910.65 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,575.00 and a high of ₹3,041.95. In terms of performance, Gland Pharma Ltd share price has increased by 82.25% over the past six months and has increased by 46.79% over the last year.
GLAND Stock Price Chart
Gland Pharma Ltd Overview
Market cap₹48,875 Crs
Volume1,62,074
Prev. Close₹2,910.65
Year range₹1,575.00 - ₹3,041.95
ISININE068V01023
About GLAND
Gland Pharma is primarily engaged in manufacturing injectable formulations.
Gland Pharma Ltd Historical Performance
1 Month Return3.60%
6 Month Return78.06%
3 Year Return74.61%
3 Month Return34.57%
1 Year Return46.82%
5 Year Return-23.28%
Gland Pharma Ltd Fundamentals
ROCE(TTM)16.34%
P/E Ratio (TTM)35.04
P/B Ratio4.52
Debt to Equity0.00
ROE12.02%
EPS (TTM)85.60
Dividend Yield0.67%
Book Value655.11
Profit Margin29.43%
Operating Margin33.36%
Gland Pharma Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 4,855.99 | 4,331.23 | 4,334.10 | 3,856.99 | 4,624.65 |
| EBITDA | 1,942.62 | 1,657.70 | 1,575.45 | 1,202.55 | 1,734.58 |
| Net Profit | 1,299.55 | 1,089.75 | 1,043.33 | 775.83 | 1,212.16 |
| EPS | 78.88 | 66.15 | 63.35 | 47.12 | 73.84 |
Gland Pharma Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 2,838.50 |
| Resistance 1 (R1) | 2,961.85 |
| Pivot Point | 2,889.70 |
Gland Pharma Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 11-Aug-2026 | 15-May-2026 | 11-Aug-2026 | Final | ₹20.00 |
| 14-Aug-2025 | 20-May-2025 | 14-Aug-2025 | Final | ₹18.00 |
| 16-Aug-2024 | 22-May-2024 | 16-Aug-2024 | Final | ₹20.00 |
GLAND Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| SRINIVAS SADU | Chairman |
| Jia Ai (Allen) Zhang | Non Executive Independent Director |
| Wenjie Zhang | Non Executive Independent Director |
Gland Pharma Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,837.30-1.61% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,375.00+0.56% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,840.00-0.72% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Gland Pharma Ltd today is ₹2,961.90 on NSE and ₹2,961.90 on BSE.
- The 52-week high of Gland Pharma Ltd is ₹3,041.95, while the 52-week low is ₹1,575.00.
- The current market capitalisation of Gland Pharma Ltd is approximately ₹48,875 crore.
- The P/E (Price-to-Earnings) ratio of Gland Pharma Ltd is 33.25. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Gland Pharma Ltd is 2.95. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Gland Pharma Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for GLAND on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Gland Pharma Ltd has delivered a return of approximately 74.61%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Gland Pharma Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 51.77% promoters, -19.49% FIIs, 30.44% DIIs, and 3.50% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
